Trial Profile

The Effects of Weight Reduction With Orlistat vs. Placebo on Changes in Body Composition.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 18 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Orlistat (Primary)
Indications Obesity; Overweight
Focus Therapeutic Use
Sponsors GlaxoSmithKline; GSK

Most Recent Events

06 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
05 Oct 2011 Results presented at the 2011 Annual Meeting of the North American Association for the Study of Obesity.
30 Jun 2011 Results published in Obesity

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com